A Phase 2 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders

Clinical trial NCT06745518 · COMPLETED

Trial details

NCT number: NCT06745518
Sponsor: Taisho Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hyperphosphatemia Patients on Hemodialysis

Start date: 2025-01-06
Primary completion: 2025-07-15
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.